$7.03
Biophytis SA is a biotechnology business based in the US. Biophytis SA shares (BPTS) are listed on the NASDAQ and all prices are listed in US Dollars. Biophytis SA employs 22 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Biophytis stock
How to buy Biophytis SA stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BPTS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Biophytis SA stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Biophytis SA stock price (NASDAQ: BPTS)
Use our graph to track the performance of BPTS stocks over time.Biophytis SA shares at a glance
Latest market close | $7.03 |
---|---|
52-week range | $5.44 - $82.40 |
50-day moving average | $14.20 |
200-day moving average | $30.20 |
Wall St. target price | $6,000.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-128.39 |
Is it a good time to buy Biophytis SA stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Biophytis SA price performance over time
Historical closes compared with the close of $7.03 from 2024-06-27
1 week (2024-08-27) | N/A |
---|---|
1 month (2024-08-03) | N/A |
3 months (2024-06-07) | -0.85% |
6 months (2024-03-07) | 1,380.00% |
1 year (2023-09-07) | 402.14% |
---|---|
2 years (2022-09-07) | 533.33% |
3 years (2021-09-07) | 8.85 |
5 years (2019-09-03) | N/A |
Biophytis SA financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -52.78% |
Return on equity TTM | -1244.4% |
Profit margin | 0% |
Book value | $0.00 |
Market Capitalization | $2.6 million |
TTM: trailing 12 months
Biophytis SA share dividends
We're not expecting Biophytis SA to pay a dividend over the next 12 months.
You may also wish to consider:
- CVS Health (CVS.US) (4.65% forward annual dividend yield)
- UnitedHealth Group Incorporated (UNH.US) (1.42% forward annual dividend yield)
- McKesson Corporation (MCK.US) (0.55% forward annual dividend yield)
Have Biophytis SA's shares ever split?
Biophytis SA's shares were split on a 1:40 basis on 22 April 2024. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Biophytis SA shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Biophytis SA shares which in turn could have impacted Biophytis SA's share price.
Biophytis SA share price volatility
Over the last 12 months, Biophytis SA's shares have ranged in value from as little as $5.44 up to $82.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biophytis SA's is 1.05. This would suggest that Biophytis SA's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Biophytis SA's beta into context you can compare it against those of similar companies.
- CVS Health (CVS.US): 0.528
- UnitedHealth Group Incorporated (UNH.US): 0.603
- McKesson Corporation (MCK.US): 0.441
Biophytis SA overview
Biophytis S. A. , a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD.
Frequently asked questions
nullWhat percentage of Biophytis SA is owned by institutions?
Currently 0.045% of Biophytis SA shares are held by institutions. How many people work for Biophytis SA?
Latest data suggests 22 work at Biophytis SA. When does the fiscal year end for Biophytis SA?
Biophytis SA's fiscal year ends in December. Where is Biophytis SA based?
Biophytis SA's address is: Sorbonne University, Paris, France, 75005 What is Biophytis SA's ISIN number?
Biophytis SA's international securities identification number is: US09076G1040
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question